The Electronic Asthma Management System

NCT03193242 | Not Yet Recruiting

• 1 other identifier: 10-052A
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 2

Brief Summary

This study is an extension of a pilot study in which investigators developed and tested a computerized tool to help physicians to determine if their patients' asthma is well controlled, advise them on medication changes required according to the current level of control, and automatically generate an electronic version of the AAP, all based on patient responses to a questionnaire completed by patients on a tablet computer. In this phase patients will have the ability to complete the questionnaire on their smartphones, through a pre-downloaded app and will have access to an electronic asthma self-management app.

Conditions

Asthma

Keywords

Asthma; Asthma Action Plan

Outcome Measures

Primary Outcomes (1)

• Proportion of Received AAP

  The study's primary outcome will be the proportion of patients currently on a controller medication who received an AAP in the intervention sites compared to the control sites, over 1 year (as determined through an electronic chart review).

  12 Months

Secondary Outcomes (9)

• Documented Asthma Control

  12 months

• Any Medication Change

  12 months

• Appropriate Medication Change

  12 months

• Healthcare utilization rate

  12 months

• Quality of life

  12 months

Study Arms (2)

Intervention

EXPERIMENTAL

Electronic Asthma Management System: eAMS Intervention eAMS consists of simple questionnaire completed either through an app on a patient's smartphone or tablet computer, a computerized clinical decision support system which then processes these data to produce a set of asthma care recommendations for the clinician, and a printable asthma action plan that is given to patients. eAMS will also provide access to a patient-oriented asthma management tool called Breathe.

Other: Electronic Asthma Management System: eAMS

Control

NO INTERVENTION

Electronic Asthma Management System: eAMS - Control At control sites, eligible clinicians will be offered access to the web-based clinician-oriented asthma action plan (AAP) educational module produced by the Lung Association, copies of the Canadian Asthma Guidelines, and standard fillable paper-based AAPs (the eAMS will be offered after study end).

Interventions

Electronic Asthma Management System: eAMS OTHER

Electronic Asthma Management System: eAMS Intervention eAMS consists of simple questionnaire completed either through an app on a patient's smartphone or tablet computer, a computerized clinical decision support system which then processes these data to produce a set of asthma care recommendations for the clinician, and a printable asthma action plan that is given to patients. eAMS will also provide access to a patient-oriented asthma management tool called Breathe.

Intervention

Eligibility Criteria

• Age: 16 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Eligible physicians will include all primary care physicians at the 4 sites.
• Eligible patients will include:
• patients with asthma, as determined by a validated electronic chart record search algorithm for asthma; patients \>/= 16 years of age.

You may not qualify if:

• Patients who received an AAP within the last 6 months (from their primary care physician, a respirologist, or any other source).
• Pregnant patients will be excluded given that conventional AAP recommendations may not be appropriate in this population.

Sponsors & Collaborators

• Unity Health Toronto: lead
• Ontario Lung Association: collaborator

Study Sites (2)

Wise Elephant Family Health Team

Brampton, Ontario, L6X 1N3, Canada

Location

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 9, 2017
• First Posted: June 20, 2017
• Study Start: December 1, 2024
• Primary Completion: December 1, 2025
• Study Completion (Estimated): June 1, 2026
• Last Updated: May 10, 2023

Record last verified: 2023-05

Locations

CA (2)